Travis Biechele

Chief Scientific Officer Shasqi Inc.

Seminars

Wednesday 14th October 2026
Utilizing Theranostics & Quantitive Systems Pharmacology to Enhance Translatability of Pre-Targeted ADC Therapies
12:00 pm
  • Discussing the importance of QSP modeling to determine translation of ADC dosing paradigms between animal and human studies 
  • Leveraging theranostics to better determine efficacy and safety of ADCs in the clinic
  • Using PDX models to explore relationships between antigen expression level and efficacy
Travis Biechele - Speaker at 17th World ADC San Diego Summit